Major pharmaceutical companies continually research and develop new melanoma/skin cancer drugs and treatments, which must be shown to be safe and effective before doctors can prescribe them to patients. Through clinical trials, researchers test the effects of new medications on a group of volunteers with melanoma/skin cancer. Following a strict protocol and using carefully controlled conditions, researchers evaluate the investigational drugs under development and measure the ability of the new drug to treat the cancer, the safety of the new drug, and any possible side effects.
Some patients with melanoma/skin cancer are reluctant to take part in clinical trials for fear of getting no treatment at all. This is simply not true. Patients with melanoma/skin cancer who participate in cancer clinical trials receive the most effective therapy available -- or they may receive treatments that are being evaluated for future use. These melanoma/skincancer drugs may be even more effective than the current treatment.
Skin cancers involve abnormal cell changes in the outer layer of skin.
It is by far the most common cancer in the world, accounting for 75% of all cancer diagnoses. Most cases are cured, but the disease is a major health concern because it affects so many people. The incidence of skin cancer is rising, even though most cases could be prevented by limiting the skin's exposure to ultraviolet radiation.
Skin cancer is about three times more common in men than in women, and the...
This web site, developed by the nonprofit Coalition of Cancer Cooperative Groups, is an unbiased cancer clinical trial matching and navigation service enabling patients to search for cancer trials based on disease and location.